Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 3—March 2017
CME ACTIVITY - Synopsis

Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002–2014

Jennifer A. DavidsonComments to Author , Miranda G. Loutet, Catherine O’Connor, Cathriona Kearns, Robert M.M. Smith, Maeve K. Lalor, H. Lucy Thomas, Ibrahim Abubakar, and Dominik Zenner
Author affiliations: Public Health England, London, UK (J.A. Davidson, M.G. Loutet, C. O’Connor, M.K. Lalor, H.L. Thomas, I. Abubakar, D. Zenner); P; ublic Health Agency Northern Ireland, Belfast, Ireland, UK (C. Kearns); Public Health Wales, Cardiff, Wales, UK (R.M.M. Smith); University College London, London (M.K. Lalor, H.L Thomas, I. Abubakar, D. Zenner)

Main Article

Figure 2

Annual number of notified UK-born Mycobacterium bovis cases, by patient age group, England, Wales, and Northern Ireland, 2002–2014.

Figure 2. Annual number of notified UK-born Mycobacterium bovis cases, by patient age group, England, Wales, and Northern Ireland, 2002–2014.

Main Article

Page created: February 15, 2017
Page updated: February 15, 2017
Page reviewed: February 15, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external